Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population
Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Jun 2, 2017
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
Up to 80 participants may be recruited to this study at Moffitt Cancer Center to obtain a final sample size of 60 completed participants.
Participants will be identified in consultation with the patient's primary oncologist and program social worker. A research assistant (RA) will verify eligibility and consent eligible patients.
After completing a baseline questionnaire, participants will be randomly placed into one of two groups. Both groups will receive their normal care, but one group will also meet with a patient navigator. Participants in both groups will be asked to complete a foll...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 18 to 39 years old.
- • Will undergo chemotherapy and/or radiotherapy and/or surgery with no plans to undergo a transplant procedure within the next 3 months.
- • Have no previous cancer history other than non-melanoma skin cancer.
- • Able to speak and read English.
- • Able to provide written informed consent.
- Exclusion Criteria:
- • Does not meet any of the Inclusion Criteria.
About H. Lee Moffitt Cancer Center And Research Institute
H. Lee Moffitt Cancer Center and Research Institute is a leading institution dedicated to cancer research, treatment, and education, recognized for its commitment to advancing cancer care through innovative clinical trials and groundbreaking research. As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt integrates cutting-edge science with patient-centered care, offering a multidisciplinary approach to cancer treatment. The center is at the forefront of developing novel therapies and improving outcomes for patients, emphasizing collaboration between researchers and clinicians to translate scientific discoveries into effective treatments. Through its extensive clinical trial programs, Moffitt aims to enhance the understanding of cancer biology and provide patients with access to the latest therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tampa, Florida, United States
Patients applied
Trial Officials
Kristine Donovan, PhD, MBA
Principal Investigator
H. Lee Moffitt Cancer Center and Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials